Long-Term Suppressive Therapy for Candida parapsilosis-Induced Prosthetic Valve Endocarditis

26Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Prompt valve replacement is advocated in patients in whom candidal prosthetic valve endocarditis develops. Unfortunately, some patients with this condition are considered nonsurgical candidates, and they are unable to tolerate long-term administration of amphotericin B with or without flucytosine. Herein we describe a patient with Candida parapsilosis-induced prosthetic valve endocarditis in whom oral administration of fluconazole during an 11-month period successfully suppressed the fungal infection. Three previously published cases indicate that long-term noncurative suppressive therapy for C. parapsilosis-induced prosthetic valve endocarditis may allow prolonged symptom-free survival for such patients. © 1995, Mayo Foundation for Medical Education and Research. All rights reserved.

Author supplied keywords

Cite

CITATION STYLE

APA

Baddour, L. M. (1995). Long-Term Suppressive Therapy for Candida parapsilosis-Induced Prosthetic Valve Endocarditis. Mayo Clinic Proceedings, 70(8), 773–775. https://doi.org/10.4065/70.8.773

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free